Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 52533 [2010-21267]

Download as PDF Federal Register / Vol. 75, No. 165 / Thursday, August 26, 2010 / Notices the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Individuals who would like to submit written statements should e-mail or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Those wishing to register to attend the meeting may do so by sending an e-mail to nvpo@hhs.gov or by calling 202–690– 5566 and providing name, e-mail address and organization. Dated: August 23, 2010. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. 2010–21263 Filed 8–25–10; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Department of Health and Human Services, Office of Public Health and Science, The Presidential Commission for the Study of Bioethical Issues. ACTION: Notice of meeting. AGENCY: The Presidential Commission for the Study of Bioethical Issues will conduct a meeting in September. At this meeting, the Commission will continue discussing the emerging science of synthetic biology, including its potential benefits and risks, and appropriate ethical boundaries and principles. DATES: The meeting will take place Monday, September 13, 2010, from 8:50 a.m. to approximately 4:15 p.m., and Tuesday, September 14, 2010, from 9 a.m. to approximately noon. ADDRESSES: Monday, September 13, The Inn at Penn, 3600 Sansom Street, Philadelphia, PA 19104. Phone 215– 222–0200. Tuesday, September 14, The Annenberg Public Policy Center, 202 South 36th Street, Philadelphia, PA 19104. Phone 215–898–9400. FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of Communications, The Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue, NW., Suite C–100, Washington, DC 20005. Telephone: 202/233–3960. E-mail: info@bioethics.gov. Additional information may be obtained by viewing the Web site: https://www.bioethics.gov. SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee Act, mstockstill on DSKH9S0YB1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 20:12 Aug 25, 2010 Jkt 220001 Public Law 92–463, 5 U.S.C. App., notice is hereby given that the Presidential Commission for the Study of Bioethical Issues (PCSBI) will be conducting a meeting. The meeting will be held from 8:50 a.m. to approximately 4:15 p.m. on Monday, September 13, 2010, at the Inn at Penn, 3600 Sansom Street, Philadelphia, PA 19104, and from 9 a.m. to approximately noon on Tuesday, September 14, 2010, at The Annenberg Public Policy Center, 202 South 36th Street, Philadelphia, PA 19104. The meeting will be open to the public with attendance limited to space available. The meeting will also be Web cast. Under authority of Executive Order 13521, dated November 24, 2009, the President established the PCSBI to serve as a public forum and advise him on bioethical issues generated by novel and emerging research in biomedicine and related areas of science and technology. The Commission is charged to identify and promote policies and practices that assure ethically responsible conduct of scientific research, healthcare delivery, and technological innovation. In undertaking these duties, the Commission will examine specific bioethical, legal, and social issues related to potential scientific and technological advances; examine diverse perspectives and possibilities for useful international collaboration on these issues, and recommend legal, regulatory, or policy actions as appropriate. The main agenda items for this meeting involve further discussion of the opportunities and benefits to the public of the emerging science of synthetic biology, the challenges and risks, and the ethical boundaries that may be important to formulation of public policy with regard to this advancing science. The Commission also will hear more from the perspective of faith communities and others. The draft meeting agenda and other information about PCSBI, including information about access to the Web cast, will be available at https:// www.bioethics.gov. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Individuals who would like to provide public comment at the meeting should notify Ms. Diane Gianelli, Director of Communications, by telephone at 202– 233–3960, or e-mail at diane.gianelli@bioethics.gov. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should also notify Ms. Gianelli in advance of the meeting. The Commission will make PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 52533 every effort to accommodate persons who need special assistance. Written comments will also be accepted in accord with the Commission’s existing request for public comment on the issues before the Commission. Please address written comments by e-mail to info@bioethics.gov, or by mail to the following address: Public Commentary, The Presidential Commission for the Study of Bioethical Issues, 1425 New York Ave., NW., Suite C–100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Dated: August 17, 2010. Valerie H. Bonham, Executive Director, The Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2010–21267 Filed 8–25–10; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Proposed Collection: Comment Request In compliance with the requirement for opportunity for public comment on proposed data collection projects (section 3506(c)(2)(A) of Title 44, United States Code, as amended by the Paperwork Reduction Act of 1995, Pub. L. 104–13), the Health Resources and Services Administration (HRSA) publishes periodic summaries of proposed projects being developed for submission to the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To request more information on the proposed project or to obtain a copy of the data collection plans and draft instruments, e-mail paperwork@hrsa.gov or call the HRSA Reports Clearance Officer at (301) 443– 1129. Comments are invited on: (a) The proposed collection of information for the proper performance of the functions of the agency; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. E:\FR\FM\26AUN1.SGM 26AUN1

Agencies

[Federal Register Volume 75, Number 165 (Thursday, August 26, 2010)]
[Notices]
[Page 52533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-21267]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Department of Health and Human Services, Office of Public 
Health and Science, The Presidential Commission for the Study of 
Bioethical Issues.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
will conduct a meeting in September. At this meeting, the Commission 
will continue discussing the emerging science of synthetic biology, 
including its potential benefits and risks, and appropriate ethical 
boundaries and principles.

DATES: The meeting will take place Monday, September 13, 2010, from 
8:50 a.m. to approximately 4:15 p.m., and Tuesday, September 14, 2010, 
from 9 a.m. to approximately noon.

ADDRESSES: Monday, September 13, The Inn at Penn, 3600 Sansom Street, 
Philadelphia, PA 19104. Phone 215-222-0200. Tuesday, September 14, The 
Annenberg Public Policy Center, 202 South 36th Street, Philadelphia, PA 
19104. Phone 215-898-9400.

FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of 
Communications, The Presidential Commission for the Study of Bioethical 
Issues, 1425 New York Avenue, NW., Suite C-100, Washington, DC 20005. 
Telephone: 202/233-3960. E-mail: info@bioethics.gov. Additional 
information may be obtained by viewing the Web site: https://www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act, Public Law 92-463, 5 U.S.C. App., notice is hereby given that the 
Presidential Commission for the Study of Bioethical Issues (PCSBI) will 
be conducting a meeting. The meeting will be held from 8:50 a.m. to 
approximately 4:15 p.m. on Monday, September 13, 2010, at the Inn at 
Penn, 3600 Sansom Street, Philadelphia, PA 19104, and from 9 a.m. to 
approximately noon on Tuesday, September 14, 2010, at The Annenberg 
Public Policy Center, 202 South 36th Street, Philadelphia, PA 19104. 
The meeting will be open to the public with attendance limited to space 
available. The meeting will also be Web cast.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the PCSBI to serve as a public forum and 
advise him on bioethical issues generated by novel and emerging 
research in biomedicine and related areas of science and technology. 
The Commission is charged to identify and promote policies and 
practices that assure ethically responsible conduct of scientific 
research, healthcare delivery, and technological innovation. In 
undertaking these duties, the Commission will examine specific 
bioethical, legal, and social issues related to potential scientific 
and technological advances; examine diverse perspectives and 
possibilities for useful international collaboration on these issues, 
and recommend legal, regulatory, or policy actions as appropriate. The 
main agenda items for this meeting involve further discussion of the 
opportunities and benefits to the public of the emerging science of 
synthetic biology, the challenges and risks, and the ethical boundaries 
that may be important to formulation of public policy with regard to 
this advancing science. The Commission also will hear more from the 
perspective of faith communities and others. The draft meeting agenda 
and other information about PCSBI, including information about access 
to the Web cast, will be available at https://www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Individuals who would like to provide 
public comment at the meeting should notify Ms. Diane Gianelli, 
Director of Communications, by telephone at 202-233-3960, or e-mail at 
diane.gianelli@bioethics.gov. Anyone planning to attend the meeting who 
needs special assistance, such as sign language interpretation or other 
reasonable accommodations, should also notify Ms. Gianelli in advance 
of the meeting. The Commission will make every effort to accommodate 
persons who need special assistance.
    Written comments will also be accepted in accord with the 
Commission's existing request for public comment on the issues before 
the Commission. Please address written comments by e-mail to 
info@bioethics.gov, or by mail to the following address: Public 
Commentary, The Presidential Commission for the Study of Bioethical 
Issues, 1425 New York Ave., NW., Suite C-100, Washington, DC 20005. 
Comments will be publicly available, including any personally 
identifiable or confidential business information that they contain. 
Trade secrets should not be submitted.

    Dated: August 17, 2010.
Valerie H. Bonham,
Executive Director, The Presidential Commission for the Study of 
Bioethical Issues.
[FR Doc. 2010-21267 Filed 8-25-10; 8:45 am]
BILLING CODE 4154-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.